Tennessee BOP heeds APC’s recommendations
Heeding APC's recommendations, the Board voted at its May 8 hearing to strike this language from the rules, removing this potentially burdensome change.
Heeding APC's recommendations, the Board voted at its May 8 hearing to strike this language from the rules, removing this potentially burdensome change.
FDA Commissioner Dr. Robert Califf recently acknowledged the importance of compounding for addressing drug shortages during emergencies.
Compounding pharmacies using OutcomeMD, a patient-reported outcomes (PROs) tool, can now join our user group. As an APC member, you can access this tool at a special members-only subscription rate.
Showcasing patient testimonials in your compounding pharmacy's waiting area can have a significant impact on building trust with your patients and improving their experience.
Three state boards of pharmacy recently issued licensee communications that contained incorrect information about FDA guidance on shortage drug compounding by 503A pharmacies.
We have updated our USP state-by-state implementation tracking spreadsheet, and it’s available online here—but only to APC members. This resource shows the status of implementation of USP 795, 797, and 800 chapters in every state.
In a letter sent this week to NABP, FDA clarified its position on the compounding of semaglutide sodium.
Help us help prescribers understand the importance of preserving compounded hormone therapy.
A recent article revealed that the National Academies of Science, Engineering and Medicine reportedly received funds—to the tune of $19 million—from members of the Sackler family.
The California Board of Pharmacy met yesterday to discuss proposed regulations on non-sterile, sterile, and hazardous compounding.